These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27404330)

  • 1. Why I'm Holding onto Hope for Nano in Oncology.
    Allen C
    Mol Pharm; 2016 Aug; 13(8):2603-4. PubMed ID: 27404330
    [No Abstract]   [Full Text] [Related]  

  • 2. Bankruptcy filing worries developers of nanoparticle cancer drugs.
    Ledford H
    Nature; 2016 May; 533(7603):304-5. PubMed ID: 27193658
    [No Abstract]   [Full Text] [Related]  

  • 3. Transport Barriers and Oncophysics in Cancer Treatment.
    Nizzero S; Ziemys A; Ferrari M
    Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Nanomedicine: Lessons for Immuno-Oncology.
    Sengupta S
    Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities.
    Mohamed NK; Hamad MA; Hafez MZ; Wooley KL; Elsabahy M
    Int J Cancer; 2017 Apr; 140(7):1475-1484. PubMed ID: 27861850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is smaller better?
    Wallner PE
    J Am Coll Radiol; 2004 Dec; 1(12):904-5. PubMed ID: 17411730
    [No Abstract]   [Full Text] [Related]  

  • 7. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in the use of nanocarriers for cancer diagnosis and treatment.
    Vieira DB; Gamarra LF
    Einstein (Sao Paulo); 2016; 14(1):99-103. PubMed ID: 27074238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology: Future of Oncotherapy.
    Gharpure KM; Wu SY; Li C; Lopez-Berestein G; Sood AK
    Clin Cancer Res; 2015 Jul; 21(14):3121-30. PubMed ID: 26180057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanooncology: the future of cancer diagnosis and therapy.
    Thakor AS; Gambhir SS
    CA Cancer J Clin; 2013; 63(6):395-418. PubMed ID: 24114523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport Oncophysics in silico, in vitro, and in vivo. Preface.
    Koay EJ; Ferrari M
    Phys Biol; 2014 Nov; 11(6):060201. PubMed ID: 25426742
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomal therapies in oncology: does one size fit all?
    Sousa I; Rodrigues F; Prazeres H; Lima RT; Soares P
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):741-755. PubMed ID: 30116847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in nanooncology.
    Jain KK
    Technol Cancer Res Treat; 2008 Feb; 7(1):1-13. PubMed ID: 18198919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms.
    Song W; Das M; Chen X
    Trends Cancer; 2020 Apr; 6(4):288-298. PubMed ID: 32209444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Themed issue on Cancer Nanotechnology.
    Grodzinski P
    Integr Biol (Camb); 2013 Jan; 5(1):17-8. PubMed ID: 23179042
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.
    Di Lorenzo G; Kreuter A; Di Trolio R; Guarini A; Romano C; Montesarchio V; Brockmeyer NH; De Placido S; Bower M; Dezube BJ
    J Invest Dermatol; 2008 Jun; 128(6):1578-80. PubMed ID: 18185536
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
    Zhang Y; Ho SH; Li B; Nie G; Li S
    Med Res Rev; 2020 May; 40(3):1084-1102. PubMed ID: 31709590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine applications in the treatment of breast cancer: current state of the art.
    Wu D; Si M; Xue HY; Wong HL
    Int J Nanomedicine; 2017; 12():5879-5892. PubMed ID: 28860754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIPEC: the complexities of clinical trials.
    Bartlett DL
    Ann Surg Oncol; 2008 May; 15(5):1277-9. PubMed ID: 18324445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.